Lam, Byron L.
Massachusetts Eye and Ear Infirmary · Children's Hospital of Philadelphia · Harvard University · University of Michigan · Editas Medicine (United States) · University of Pennsylvania
15 papers on CoChatORCID 0000-0002-1233-2366
Most cited papers
- Verified
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies
Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., Hubschman, J.-P., Davis, J. L., Heilwell, G., Spirn, M., et al. (2015) · The Lancet
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 1,327
- Verified · note
Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR
Cehajic-Kapetanovic, J., Xue, K., Martinez-Fernandez de la Camara, C., Nanda, A., Davies, A., Wood, L. J., Salvetti, A. P., Fischer, M. D., Aylward, J. W., Barnard, A. R., et al. (2020) · Nature Medicine
Retinal Development and DisordersVirus-based gene therapy research
Cited by 368
- Verified
Gene Editing for CEP290 -Associated Retinal Degeneration
Pierce, E. A., Aleman, T. S., Jayasundera, K. T., Ashimatey, B. S., Kim, K., Rashid, A., Jaskolka, M. C., Myers, R. L., Lam, B. L., Bailey, S. T., et al. (2024) · New England Journal of Medicine
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 237
- Verified
Gene Therapy for Leber Hereditary Optic Neuropathy
Feuer, W. J., Schiffman, J. C., Davis, J. L., Porciatti, V., Gonzalez, P., Koilkonda, R. D., Yuan, H., Lalwani, A., Lam, B. L., & Guy, J. (2016) · Ophthalmology
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 230
- Verified
Gene Therapy for Leber Hereditary Optic Neuropathy
Guy, J., Feuer, W. J., Davis, J. L., Porciatti, V., Gonzalez, P. J., Koilkonda, R. D., Yuan, H., Hauswirth, W. W., & Lam, B. L. (2017) · Ophthalmology
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 204
- Verified
Choroideremia gene therapy phase 2 clinical trial: 24-month results
Lam, B. L., Davis, J. L., Gregori, N. Z., MacLaren, R. E., Girach, A., Verriotto, J. D., Rodriguez, B., Rosa, P. R., Zhang, X., & Feuer, W. J. (2019) · American Journal of Ophthalmology
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 161
- Verified · note
Trial End Points and Natural History in Patients With G11778A Leber Hereditary Optic Neuropathy: Preparation for Gene Therapy Clinical Trial
Lam, B. L., Feuer, W. J., Schiffman, J. C., Porciatti, V., Vandenbroucke, R., Rosa, P. R., Gregori, G., & Guy, J. (2014) · JAMA Ophthalmology
Glaucoma and retinal disordersRetinal Development and Disorders
Cited by 96
- Verified
Surgical technique for subretinal gene therapy in humans with inherited retinal degeneration
Davis, J. L., Gregori, N. Z., MacLaren, R. E., & Lam, B. L. (2019) · Retina
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 72
- Verified
Pain in Anterior Ischemic Optic Neuropathy
Swartz, N. G., Beck, R. W., Savino, P. J., Sergott, R. C., Bosley, T. M., Lam, B. L., Drucker, M., & Katz, B. (1995) · Journal of Neuro-Ophthalmology
Multiple Sclerosis Research StudiesGlaucoma and retinal disorders
Cited by 70
- Verified
Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial
MacLaren, R. E., Fischer, M. D., Gow, J. A., Lam, B. L., Sankila, E.-M. K., Girach, A., Panda, S., Yoon, D., Zhao, G., & Pennesi, M. E. (2023) · Nature Medicine
Retinal Development and DisordersVirus-based gene therapy research
Cited by 58
- Verified
Stargardt macular dystrophy and evolving therapies
Hussain, R. M., Ciulla, T. A., Berrocal, A. M., Gregori, N. Z., Flynn, H. W., & Lam, B. L. (2018) · Expert Opinion on Biological Therapy
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 56
- Verified
Intraoperative use of microscope-integrated optical coherence tomography for subretinal gene therapy delivery
Gregori, N. Z., Lam, B. L., & Davis, J. L. (2019) · Retina
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 54
- Verified
Assessment of visual function with cotoretigene toliparvovec in X-linked retinitis pigmentosa in the randomized XIRIUS phase 2/3 study
Lam, B. L., Pennesi, M. E., Kay, C. N., Panda, S., Gow, J. A., Zhao, G., MacLaren, R. E., MacLaren, R., Aleman, T., Birch, D., et al. (2024) · Ophthalmology
Retinal Development and DisordersVirus-based gene therapy research
Cited by 51
- Verified
Leber hereditary optic neuropathy gene therapy: adverse events and visual acuity results of all patient groups
Lam, B. L., Feuer, W. J., Davis, J. L., Porciatti, V., Yu, H., Levy, R. B., Vanner, E., & Guy, J. (2022) · American Journal of Ophthalmology
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 43
- Verified
An open-label phase II study assessing the safety of bilateral, sequential administration of retinal gene therapy in participants with choroideremia: the GEMINI study
MacLaren, R. E., Audo, I., Fischer, M. D., Huckfeldt, R. M., Lam, B. L., Pennesi, M. E., Sisk, R., Gow, J. A., Li, J., Zhu, K., et al. (2024) · Human Gene Therapy
Retinal Development and DisordersVirus-based gene therapy research
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free